Induction of donor-specific immune modulation and successful renal transplantation with a simplified method of donor-specific blood transfusion

J. S. Cheigh, Manikkam Suthanthiran, M. Fotino, M. Kaplan, M. Evelyn, N. Schechter, C. F. Wolf, R. R. Riggio, R. Riehle, W. T. Stubenbord

Research output: Contribution to journalArticle

Abstract

We developed a new method of donor-specific blood transfusion (DST) for prospective kidney transplant recipients from a living related donor. Forty-four patients were transfused with 100 ml of one-haplotype matched kidney donor's whole blood at 1, 8, and 15 days after its storage. Ten of these patients received azathioprine (1.5 mg/kg per day) in addition to DST. After DST, three patients (6.8%) developed donor-specific lymphocytotoxic antibodies. The incidence of sensitization was not different between azathioprine-treated and untreated patients. Following DST, donor-specific mixed lymphocyte culture (MLC) was significantly suppressed without any accelerated (secondary type) response in early MLC. Subsequently, 24 patients received a kidney transplant from the donor. Graft survival rates were 96% and 90% at 12 and 24 months, respectively. Nine additional patients, seven from a two-haplotype matched sibling and two from a no-haplotype matched sibling also received DST. None of these patients became sensitized following DST, and all have functioning grafts for 6 to 18 months. This study indicates that (i) 100 ml of stored whole blood DST three times at weekly intervals is a practical, less immunizing, and effective approach to enhance graft survival in recipients of a living related donor graft, (ii) DST produces donor-specific adaptive responses that might be conducive to successful graft outcome, and (iii) this protocol could be used in sibling donor-recipient pairs who do not share a haplotype.

Original languageEnglish
Pages (from-to)11-17
Number of pages7
JournalUremia Investigation
Volume9
Issue number1
Publication statusPublished - 1 Dec 1985
Externally publishedYes

Fingerprint

Blood Transfusion
Kidney Transplantation
Tissue Donors
Haplotypes
Siblings
Living Donors
Azathioprine
Graft Survival
Blood Donors
Transplants
Kidney
Lymphocytes
Antilymphocyte Serum
Survival Rate

ASJC Scopus subject areas

  • Nephrology

Cite this

Induction of donor-specific immune modulation and successful renal transplantation with a simplified method of donor-specific blood transfusion. / Cheigh, J. S.; Suthanthiran, Manikkam; Fotino, M.; Kaplan, M.; Evelyn, M.; Schechter, N.; Wolf, C. F.; Riggio, R. R.; Riehle, R.; Stubenbord, W. T.

In: Uremia Investigation, Vol. 9, No. 1, 01.12.1985, p. 11-17.

Research output: Contribution to journalArticle

Cheigh, JS, Suthanthiran, M, Fotino, M, Kaplan, M, Evelyn, M, Schechter, N, Wolf, CF, Riggio, RR, Riehle, R & Stubenbord, WT 1985, 'Induction of donor-specific immune modulation and successful renal transplantation with a simplified method of donor-specific blood transfusion', Uremia Investigation, vol. 9, no. 1, pp. 11-17.
Cheigh, J. S. ; Suthanthiran, Manikkam ; Fotino, M. ; Kaplan, M. ; Evelyn, M. ; Schechter, N. ; Wolf, C. F. ; Riggio, R. R. ; Riehle, R. ; Stubenbord, W. T. / Induction of donor-specific immune modulation and successful renal transplantation with a simplified method of donor-specific blood transfusion. In: Uremia Investigation. 1985 ; Vol. 9, No. 1. pp. 11-17.
@article{44bd019937004f8596fb77b6eedece56,
title = "Induction of donor-specific immune modulation and successful renal transplantation with a simplified method of donor-specific blood transfusion",
abstract = "We developed a new method of donor-specific blood transfusion (DST) for prospective kidney transplant recipients from a living related donor. Forty-four patients were transfused with 100 ml of one-haplotype matched kidney donor's whole blood at 1, 8, and 15 days after its storage. Ten of these patients received azathioprine (1.5 mg/kg per day) in addition to DST. After DST, three patients (6.8{\%}) developed donor-specific lymphocytotoxic antibodies. The incidence of sensitization was not different between azathioprine-treated and untreated patients. Following DST, donor-specific mixed lymphocyte culture (MLC) was significantly suppressed without any accelerated (secondary type) response in early MLC. Subsequently, 24 patients received a kidney transplant from the donor. Graft survival rates were 96{\%} and 90{\%} at 12 and 24 months, respectively. Nine additional patients, seven from a two-haplotype matched sibling and two from a no-haplotype matched sibling also received DST. None of these patients became sensitized following DST, and all have functioning grafts for 6 to 18 months. This study indicates that (i) 100 ml of stored whole blood DST three times at weekly intervals is a practical, less immunizing, and effective approach to enhance graft survival in recipients of a living related donor graft, (ii) DST produces donor-specific adaptive responses that might be conducive to successful graft outcome, and (iii) this protocol could be used in sibling donor-recipient pairs who do not share a haplotype.",
author = "Cheigh, {J. S.} and Manikkam Suthanthiran and M. Fotino and M. Kaplan and M. Evelyn and N. Schechter and Wolf, {C. F.} and Riggio, {R. R.} and R. Riehle and Stubenbord, {W. T.}",
year = "1985",
month = "12",
day = "1",
language = "English",
volume = "9",
pages = "11--17",
journal = "Renal Failure",
issn = "0886-022X",
publisher = "Informa Healthcare",
number = "1",

}

TY - JOUR

T1 - Induction of donor-specific immune modulation and successful renal transplantation with a simplified method of donor-specific blood transfusion

AU - Cheigh, J. S.

AU - Suthanthiran, Manikkam

AU - Fotino, M.

AU - Kaplan, M.

AU - Evelyn, M.

AU - Schechter, N.

AU - Wolf, C. F.

AU - Riggio, R. R.

AU - Riehle, R.

AU - Stubenbord, W. T.

PY - 1985/12/1

Y1 - 1985/12/1

N2 - We developed a new method of donor-specific blood transfusion (DST) for prospective kidney transplant recipients from a living related donor. Forty-four patients were transfused with 100 ml of one-haplotype matched kidney donor's whole blood at 1, 8, and 15 days after its storage. Ten of these patients received azathioprine (1.5 mg/kg per day) in addition to DST. After DST, three patients (6.8%) developed donor-specific lymphocytotoxic antibodies. The incidence of sensitization was not different between azathioprine-treated and untreated patients. Following DST, donor-specific mixed lymphocyte culture (MLC) was significantly suppressed without any accelerated (secondary type) response in early MLC. Subsequently, 24 patients received a kidney transplant from the donor. Graft survival rates were 96% and 90% at 12 and 24 months, respectively. Nine additional patients, seven from a two-haplotype matched sibling and two from a no-haplotype matched sibling also received DST. None of these patients became sensitized following DST, and all have functioning grafts for 6 to 18 months. This study indicates that (i) 100 ml of stored whole blood DST three times at weekly intervals is a practical, less immunizing, and effective approach to enhance graft survival in recipients of a living related donor graft, (ii) DST produces donor-specific adaptive responses that might be conducive to successful graft outcome, and (iii) this protocol could be used in sibling donor-recipient pairs who do not share a haplotype.

AB - We developed a new method of donor-specific blood transfusion (DST) for prospective kidney transplant recipients from a living related donor. Forty-four patients were transfused with 100 ml of one-haplotype matched kidney donor's whole blood at 1, 8, and 15 days after its storage. Ten of these patients received azathioprine (1.5 mg/kg per day) in addition to DST. After DST, three patients (6.8%) developed donor-specific lymphocytotoxic antibodies. The incidence of sensitization was not different between azathioprine-treated and untreated patients. Following DST, donor-specific mixed lymphocyte culture (MLC) was significantly suppressed without any accelerated (secondary type) response in early MLC. Subsequently, 24 patients received a kidney transplant from the donor. Graft survival rates were 96% and 90% at 12 and 24 months, respectively. Nine additional patients, seven from a two-haplotype matched sibling and two from a no-haplotype matched sibling also received DST. None of these patients became sensitized following DST, and all have functioning grafts for 6 to 18 months. This study indicates that (i) 100 ml of stored whole blood DST three times at weekly intervals is a practical, less immunizing, and effective approach to enhance graft survival in recipients of a living related donor graft, (ii) DST produces donor-specific adaptive responses that might be conducive to successful graft outcome, and (iii) this protocol could be used in sibling donor-recipient pairs who do not share a haplotype.

UR - http://www.scopus.com/inward/record.url?scp=0022399269&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022399269&partnerID=8YFLogxK

M3 - Article

VL - 9

SP - 11

EP - 17

JO - Renal Failure

JF - Renal Failure

SN - 0886-022X

IS - 1

ER -